Nexgel R&D Spending Growth & History (NXGL)
Nexgel's r&d spending was $2,000 for fiscal 2025.
View full Nexgel company overviewNexgel annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2,000 | −$76,000 | −97.44% |
| 2024 | 2024-12-31 | $78,000 | −$25,000 | −24.27% |
| 2023 | 2023-12-31 | $103,000 | −$264,000 | −71.93% |
| 2022 | 2022-12-31 | $367,000 | $336,000 | +1083.87% |
| 2021 | 2021-12-31 | $31,000 | — | — |
Nexgel quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $20,000 | $20,000 | — |
| Q1 2026 | 2026-03-31 | $0 | −$1,000 | — |
| Q4 2025 | 2025-12-31 | −$6,000 | −$6,000 | — |
| Q3 2025 | 2025-09-30 | $7,000 | $7,000 | — |
| Q2 2025 | 2025-06-30 | $0 | −$76,000 | — |
| Q1 2025 | 2025-03-31 | $1,000 | −$1,000 | −50.00% |
| Q4 2024 | 2024-12-31 | $0 | −$13,000 | — |
| Q3 2024 | 2024-09-30 | $0 | −$6,000 | — |
| Q2 2024 | 2024-06-30 | $76,000 | $21,000 | +38.18% |
| Q1 2024 | 2024-03-31 | $2,000 | −$27,000 | −93.10% |
| Q4 2023 | 2023-12-31 | $13,000 | −$26,000 | −66.67% |
| Q3 2023 | 2023-09-30 | $6,000 | −$187,000 | −96.89% |
| Q2 2023 | 2023-06-30 | $55,000 | −$56,000 | −50.45% |
| Q1 2023 | 2023-03-31 | $29,000 | $5,000 | +20.83% |
| Q4 2022 | 2022-12-31 | $39,000 | $25,000 | +178.57% |
| Q3 2022 | 2022-09-30 | $193,000 | $193,000 | — |
| Q2 2022 | 2022-06-30 | $111,000 | $101,000 | +1010.00% |
| Q1 2022 | 2022-03-31 | $24,000 | $17,000 | +242.86% |
| Q4 2021 | 2021-12-31 | $14,000 | — | — |
| Q3 2021 | 2021-09-30 | $0 | — | — |
| Q2 2021 | 2021-06-30 | $10,000 | — | — |
| Q1 2021 | 2021-03-31 | $7,000 | — | — |
Nexgel r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, Nexgel's r&d spending decreased from $31,000 to $2,000, a change of −$29,000. The latest reported quarter, Q2 2026, shows $20,000.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nexgel source filings ↗